Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...
Factors affecting long-term outcomes after postchemotherapy surgery in patients with nonseminomatous germ cell tumors of the mediastinum. Epidermal growth factor receptor (EGFR) targeted therapy in ...
Research by a Washington State University-led team of scientists has identified a receptor protein, CHRM1, as a key player in prostate cancer (PC) cells’ resistance to docetaxel (DTX), a chemotherapy ...
(HealthDay News) — Chemotherapy at the start of androgen-deprivation therapy (ADT) can extend the lives of men with metastatic, hormone-sensitive prostate cancer, according to research published ...
(RTTNews) - Sagent Pharmaceuticals has recalled two lots of chemotherapy drug Docetaxel Injection, USP due to potential presence of particulate matter from the stopper in the drug, according to the ...
Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 ...
Magrolimab plus docetaxel improved outcomes in metastatic NSCLC patients with high CD47 expression, showing a median PFS of 8.9 months versus 2.6 months for lower expression. The ELEVATELung&UC trial ...
What Are The Drugs, Timetable And Possible Side Effects Expected With The TAC Chemotherapy Protocol?
Dr. Clifford Hudis answers the question: 'What Is The TAC Protocol For Chemo? — -- Question: What Are The Drugs, Timetable And Possible Side Effects Expected With The TAC Chemotherapy Protocol?
A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. Over the past 14 years, ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Treatment with single-agent sacituzumab govitecan ...
A drug used to treat irritable bowel syndrome (IBS) appears to be effective against prostate cancer in mice when given in tandem with chemotherapy, a new study shows. In an article published Jan. 22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results